stockrowFortress Biotech, Inc. (FBIO) vs Telomir Pharmaceuticals, Inc. (TELO)
- Fortress Biotech, Inc. FBIO 1.83 −0.54%
- Telomir Pharmaceuticals, Inc. TELO 0.82 +5.13%
Fortress Biotech, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($61.4M and $57.5M). Telomir Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 13 metrics below, Fortress Biotech, Inc. leads on 9 and Telomir Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | FBIO | TELO | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | — | 65.16% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | (1,885.50%) | (50.12%) |
| Return on assets | 43.38% | (1,678.31%) | (45.60%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack